Lim Hyeon Su, Choi Won Il, Lim Jong-Min
Department of Electronic Materials, Devices, and Equipment Engineering, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si 31538, Chungcheongnam-do, Republic of Korea.
Center for Bio-Healthcare Materials, Bio-Convergence Materials R&D Division, Korea Institute of Ceramic Engineering and Technology, 202 Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju 28160, Chungcheongbuk-do, Republic of Korea.
Molecules. 2025 Jan 12;30(2):279. doi: 10.3390/molecules30020279.
The continuous synthesis of nanoparticles (NPs) has been actively studied due to its great potential to produce NPs with reproducible and controllable physicochemical properties. Here, we achieved the high throughput production of nanostructured lipid carriers (NLCs) using a coaxial turbulent jet mixer with an added heating system. This device, designed for the crossflow of precursor solution and non-solvent, combined with the heating system, efficiently dissolves solid lipids and surfactants. We reported the flow regime according to the Reynolds number (Re). Also, we confirmed the size controllability of NLCs as dependent on both Re and lipid concentration. The optimized synthesis yields NLCs around 80 nm, ideal for targeted drug delivery by enhanced permeability and retention (EPR) effect. The coaxial turbulent jet mixer enables effective mixing, producing uniform size distribution of NLCs. The NLCs prepared using the coaxial turbulent jet mixer were smaller, more uniform, and had higher drug loading compared to the NLCs synthesized by a bulk nanoprecipitation method, showcasing its potential for advancing nanomedicine.
由于连续合成纳米颗粒(NPs)在生产具有可重现和可控物理化学性质的纳米颗粒方面具有巨大潜力,因此该方法一直受到积极研究。在此,我们使用带有附加加热系统的同轴湍流喷射混合器实现了纳米结构脂质载体(NLCs)的高通量生产。该装置专为前体溶液和非溶剂的错流设计,并结合加热系统,能有效溶解固体脂质和表面活性剂。我们报道了根据雷诺数(Re)划分的流动状态。此外,我们证实了NLCs的尺寸可控性取决于Re和脂质浓度。优化后的合成方法可产生约80 nm的NLCs,这对于通过增强渗透和滞留(EPR)效应进行靶向药物递送而言是理想尺寸。同轴湍流喷射混合器能够实现有效混合,使NLCs的尺寸分布均匀。与通过本体纳米沉淀法合成的NLCs相比,使用同轴湍流喷射混合器制备的NLCs更小、更均匀且载药量更高,展示了其在推进纳米医学方面的潜力。
J Colloid Interface Sci. 2018-11-10
AAPS PharmSciTech. 2017-2
Int J Pharm. 2016-9-10
J Control Release. 2022-5
Pharmaceutics. 2020-5-14
J Colloid Interface Sci. 2018-11-10
Adv Drug Deliv Rev. 2018-4-5
J Nanobiotechnology. 2018-2-12